AT1 antagonists: a patent review (2008 – 2012)

Author： Mavromoustakos Thomas   Agelis George   Durdagi Serdar  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.11, 2013-11, pp. : 1483-1494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sulfonamides: a patent review (2008 – 2012)

By Carta Fabrizio   Scozzafava Andrea   Supuran Claudiu T  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 7, 2012-07 ,pp. : 747-758

Informa Healthcare

Access to resources Recommend Favorite

Androgen receptor antagonists: a patent review (2008 – 2011)

By Mohler Michael L   Coss Christopher C   Duke Charles B   Patil Shivaputra A   Miller Duane D   Dalton James T  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 541-565

Informa Healthcare

Access to resources Recommend Favorite

Glycogen phosphorylase inhibitors: a patent review (2008 - 2012)

By Gaboriaud-Kolar Nicolas   Skaltsounis Alexios-Leandros  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 1017-1032

Informa Healthcare

Access to resources Recommend Favorite

Osteoclast differentiation inhibitors: a patent review (2008 – 2012)

By Kim Seong Hwan   Moon Seong-Hee  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. : 1591-1610

Informa Healthcare

Access to resources Recommend Favorite

Secondary and tertiary sulfonamides: a patent review (2008 – 2012)

By Scozzafava Andrea   Carta Fabrizio   Supuran Claudiu T  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 2, 2013-02 ,pp. : 203-213

Informa Healthcare

Access to resources Recommend Favorite